Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression

Lin Qian^#^{1

2}, Na Li^#^{1

2

3}, Xiao-Chen Lu^#^{1

2}, Midie Xu^#^{1

4}, Ying Liu⁵, Kaiyue Li^{1

2}, Yi Zhang^{1

2}, Kewen Hu^{1

2}, Yu-Ting Qi^{1

2}, Jun Yao⁶, Ying-Li Wu⁷, Wenyu Wen^{1

8}, Shenglin Huang^{1

2}, Zheng-Jun Chen⁹, Miao Yin^{1

2}, Qun-Ying Lei^{10

11

12}

Affiliations

¹ Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences; School of Basic Medical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Radiation Oncology; The Shanghai Key Laboratory of Medical Epigenetics, Shanghai Medical College, Fudan University, Shanghai, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
³ Department of Biochemistry and Molecular Cell Biology, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁴ Department of Pathology, Fudan University Shanghai Cancer Center; Institute of Pathology, Fudan University, Shanghai, China.
⁵ Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
⁶ Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
⁷ Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Basic Medicine, Chemical Biology Division of Shanghai Universities E-Institutes, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁸ State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.
⁹ State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
¹⁰ Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences; School of Basic Medical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Radiation Oncology; The Shanghai Key Laboratory of Medical Epigenetics, Shanghai Medical College, Fudan University, Shanghai, China. qlei@fudan.edu.cn.
¹¹ Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. qlei@fudan.edu.cn.
¹² State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China. qlei@fudan.edu.cn.

^# Contributed equally.

PMID: 37337119
DOI: 10.1038/s42255-023-00818-7

Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression

Lin Qian et al. Nat Metab. 2023 Jul.

. 2023 Jul;5(7):1159-1173.

doi: 10.1038/s42255-023-00818-7. Epub 2023 Jun 19.

Authors

Affiliations

¹ Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences; School of Basic Medical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Radiation Oncology; The Shanghai Key Laboratory of Medical Epigenetics, Shanghai Medical College, Fudan University, Shanghai, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
³ Department of Biochemistry and Molecular Cell Biology, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁴ Department of Pathology, Fudan University Shanghai Cancer Center; Institute of Pathology, Fudan University, Shanghai, China.
⁵ Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
⁶ Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
⁷ Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Basic Medicine, Chemical Biology Division of Shanghai Universities E-Institutes, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁸ State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.
⁹ State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
¹⁰ Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences; School of Basic Medical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Radiation Oncology; The Shanghai Key Laboratory of Medical Epigenetics, Shanghai Medical College, Fudan University, Shanghai, China. qlei@fudan.edu.cn.
¹¹ Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. qlei@fudan.edu.cn.
¹² State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China. qlei@fudan.edu.cn.

^# Contributed equally.

PMID: 37337119
DOI: 10.1038/s42255-023-00818-7

Abstract

Increased expression of branched-chain amino acid transaminase 1 or 2 (BCAT1 and BCAT2) has been associated with aggressive phenotypes of different cancers. Here we identify a gain of function of BCAT1 glutamic acid to alanine mutation at codon 61 (BCAT1^E61A) enriched around 2.8% in clinical gastric cancer samples. We found that BCAT1^E61A confers higher enzymatic activity to boost branched-chain amino acid (BCAA) catabolism, accelerate cell growth and motility and contribute to tumor development. BCAT1 directly interacts with RhoC, leading to elevation of RhoC activity. Notably, the BCAA-derived metabolite, branched-chain α-keto acid directly binds to the small GTPase protein RhoC and promotes its activity. BCAT1 knockout-suppressed cell motility could be rescued by expressing BCAT1^E61A or adding branched-chain α-keto acid. We also identified that candesartan acts as an inhibitor of BCAT1^E61A, thus repressing RhoC activity and cancer cell motility in vitro and preventing peritoneal metastasis in vivo. Our study reveals a link between BCAA metabolism and cell motility and proliferation through regulating RhoC activation, with potential therapeutic implications for cancers.

PubMed Disclaimer

References

1. Ericksen, R. E. et al. Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes tumor development and progression. Cell Metab. 29, 1151–1165 (2019). - PubMed - PMC
1. Raffel, S. et al. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature 551, 384–388 (2017). - PubMed
1. Wang, Y. et al. Branched-chain amino acid metabolic reprogramming orchestrates drug resistance to EGFR tyrosine kinase inhibitors. Cell Rep. 28, 512–525 (2019). - PubMed
1. Tonjes, M. et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat. Med. 19, 901–908 (2013). - PubMed - PMC
1. Li, J. T. et al. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma. Nat. Cell Biol. 22, 167–174 (2020). - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression

Affiliations

Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases